BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 34321854)

  • 1. Effect of gastric microbiota on quadruple
    Niu ZY; Li SZ; Shi YY; Xue Y
    World J Gastroenterol; 2021 Jul; 27(25):3913-3924. PubMed ID: 34321854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection.
    Fu W; Song Z; Zhou L; Xue Y; Ding Y; Suo B; Tian X; Wang L
    Dig Dis Sci; 2017 Jun; 62(6):1580-1589. PubMed ID: 28391418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria.
    Hsu PI; Pan CY; Kao JY; Tsay FW; Peng NJ; Kao SS; Wang HM; Tsai TJ; Wu DC; Chen CL; Tsai KW;
    Helicobacter; 2018 Aug; 23(4):e12498. PubMed ID: 29897654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy.
    Song Z; Zhou L; Zhang J; He L; Bai P; Xue Y
    Dig Liver Dis; 2016 May; 48(5):506-511. PubMed ID: 26847964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The eradication of Helicobacter pylori restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults.
    He C; Peng C; Wang H; Ouyang Y; Zhu Z; Shu X; Zhu Y; Lu N
    Helicobacter; 2019 Aug; 24(4):e12590. PubMed ID: 31124220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The appropriate cutoff gastric pH value for Helicobacter pylori eradication with bismuth-based quadruple therapy.
    Ke H; Li J; Lu B; Yang C; Wang J; Wang Z; Liu L; Chen Y
    Helicobacter; 2021 Feb; 26(1):e12768. PubMed ID: 33089598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term changes in the gut microbiota after triple therapy, sequential therapy, bismuth quadruple therapy and concomitant therapy for Helicobacter pylori eradication in Chinese children.
    Zhou Y; Ye Z; Wang Y; Huang Z; Zheng C; Shi J; Tang W; Zhang P; Wang S; Huang Y
    Helicobacter; 2021 Aug; 26(4):e12809. PubMed ID: 33899288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Efficacy of Bismuth-containing Quadruple Therapy after Moxifloxacin-based Sequential Therapy Failure in Helicobacter pylori Eradication].
    Kwon S; Lee DH; Kang JB; Kim N; Park YS; Shin CM; Yoon H; Choi YJ
    Korean J Gastroenterol; 2018 Apr; 71(4):196-203. PubMed ID: 29684968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailored eradication
    Choi YI; Chung JW; Park DK; Kim KO; Kwon KA; Kim YJ; Seo JY
    World J Gastroenterol; 2019 Dec; 25(46):6743-6751. PubMed ID: 31857776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of furazolidone- and amoxicillin-based quadruple therapy for
    Zhang YW; Hu WL; Cai Y; Zheng WF; Du Q; Kim JJ; Kao JY; Dai N; Si JM
    World J Gastroenterol; 2018 Oct; 24(40):4596-4605. PubMed ID: 30386109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of insufficient doses of medications on
    Shi X; Wang C; Meng F; Ma S; Xu G; Liu T; Guo X; Li H; Qi X
    Postgrad Med; 2022 Sep; 134(7):668-674. PubMed ID: 35860966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A multicenter randomized controlled study of bismuth-containing quadruple therapy followed by Jing-Hua-Wei-Kang in the treatment of patients newly diagnosed with
    Ma PP; Meng LN; Wang MT; Jin HF; Fan YH; Zha AS; Huo XH; Chen DF; Cao ZQ; Tang XF; Yang P; Shi ZH; Li TW; Meng J; Gan C; Chen GX; Sha WH; Du Q; Li Y; Lyu B
    Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(26):2060-2065. PubMed ID: 34275239
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial.
    Lee JY; Kim N; Park KS; Kim HJ; Park SM; Baik GH; Shim KN; Oh JH; Choi SC; Kim SE; Kim WH; Park SY; Kim GH; Lee BE; Jo Y; Hong SJ
    BMC Gastroenterol; 2016 Jul; 16(1):79. PubMed ID: 27460100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-line rescue treatment of
    Lin TF; Hsu PI
    World J Gastroenterol; 2018 Oct; 24(40):4548-4553. PubMed ID: 30386104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China.
    Xie Y; Zhu Z; Wang J; Zhang L; Zhang Z; Lu H; Zeng Z; Chen S; Liu D; Lv N;
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of four different regimens against Helicobacter pylori as a first-line treatment: A prospective, cross-sectional, comparative, open trial in Chinese children.
    Zhou Y; Ye Z; Wang Y; Zhang Y; Tang Z; Yan W; Jiang Y; Huang Y
    Helicobacter; 2020 Apr; 25(2):e12679. PubMed ID: 31958193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori Eradication Rates in Slovenia in the Period from 2017 to 2019: Data from the European Registry on H. pylori Management.
    Tepes B; Brglez Jurecic N; Tepes K; Espada Sanchez M; Perez Nyssen O; O'Morain C; Mégraud F; Gisbert J
    Dig Dis; 2021; 39(4):318-324. PubMed ID: 33099549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Half-dose clarithromycin-containing bismuth quadruple therapy is effective and economical in treating Helicobacter pylori infection: A single-center, open-label, randomized trial.
    Lu B; Wang J; Li J; Liu L; Chen Y
    Helicobacter; 2019 Apr; 24(2):e12566. PubMed ID: 30780194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eradication Rate of
    Liu RP; Romero R; Sarosiek J; Dodoo C; Dwivedi AK; Zuckerman MJ
    South Med J; 2018 Jan; 111(1):51-55. PubMed ID: 29298370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for
    Bang CS; Lim H; Jeong HM; Shin WG; Choi JH; Soh JS; Kang HS; Yang YJ; Hong JT; Shin SP; Suk KT; Lee JJ; Baik GH; Kim DJ
    Gut Microbes; 2020 Sep; 11(5):1314-1323. PubMed ID: 32362221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.